25 XP   0   0   10

Harpoon Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Harpoon Therapeutics Inc together

PenkeI guess you are interested in Harpoon Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Harpoon Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Harpoon Therapeutics Inc

I send you an email if I find something interesting about Harpoon Therapeutics Inc.

Quick analysis of Harpoon Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Harpoon Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.25
Expected worth in 1 year
$-9.59
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
$-9.85
Return On Investment
-42.8%

For what price can you sell your share?

Current Price per Share
$23.01
Expected price per share
$22.93 - $28.90
How sure are you?
50%

1. Valuation of Harpoon Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$23.01

Intrinsic Value Per Share

$-73.21 - $-57.64

Total Value Per Share

$-72.96 - $-57.39

2. Growth of Harpoon Therapeutics Inc (5 min.)




Is Harpoon Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$5.3m$58m-$52.6m-975.6%

How much money is Harpoon Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$67.1m-$166.4m$99.2m147.9%
Net Profit Margin-210.4%-703.6%--

How much money comes from the company's main activities?

3. Financial Health of Harpoon Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#738 / 1010

Most Revenue
#189 / 1010

Most Profit
#928 / 1010

Most Efficient
#638 / 1010

What can you expect buying and holding a share of Harpoon Therapeutics Inc? (5 min.)

Welcome investor! Harpoon Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Harpoon Therapeutics Inc.

What can you expect buying and holding a share of Harpoon Therapeutics Inc?

First you should know what it really means to hold a share of Harpoon Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Harpoon Therapeutics Inc is $23.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Harpoon Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Harpoon Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.25. Based on the TTM, the Book Value Change Per Share is $-2.46 per quarter. Based on the YOY, the Book Value Change Per Share is $0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Harpoon Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-3.17-13.8%-3.17-13.8%-5.45-23.7%-2.97-12.9%-2.31-10.0%
Usd Book Value Change Per Share-2.46-10.7%-2.46-10.7%0.200.9%0.301.3%0.040.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-2.46-10.7%-2.46-10.7%0.200.9%0.301.3%0.040.2%
Usd Price Per Share0.73-0.73-7.55-7.94-5.67-
Price to Earnings Ratio-0.23--0.23--1.38--2.89--2.06-
Price-to-Total Gains Ratio-0.29--0.29-38.18-7.81-7.81-
Price to Book Ratio2.88-2.88-2.78-3.12-2.23-
Price-to-Total Gains Ratio-0.29--0.29-38.18-7.81-7.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share23.01
Number of shares43
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-2.460.30
Usd Total Gains Per Share-2.460.30
Gains per Quarter (43 shares)-105.8513.00
Gains per Year (43 shares)-423.3952.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-423-43305242
20-847-856010494
30-1270-12790156146
40-1694-17020208198
50-2117-21250260250
60-2540-25480312302
70-2964-29710364354
80-3387-33940416406
90-3811-38170468458
100-4234-42400520510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.07.00.00.0%0.07.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.05.00.028.6%2.05.00.028.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.05.00.028.6%2.05.00.028.6%

Fundamentals of Harpoon Therapeutics Inc

About Harpoon Therapeutics Inc

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; and HPN217 that is in Phase I clinical trials for the treatment of multiple myeloma. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. It has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. The company was incorporated in 2015 and is headquartered in South San Francisco, California. As of March 11, 2024, Harpoon Therapeutics, Inc. operates as a subsidiary of Merck Sharp & Dohme LLC.

Fundamental data was last updated by Penke on 2024-04-11 10:30:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Harpoon Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Harpoon Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -210.4% means that $-2.10 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harpoon Therapeutics Inc:

  • The MRQ is -210.4%. The company is making a huge loss. -2
  • The TTM is -210.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-210.4%TTM-210.4%0.0%
TTM-210.4%YOY-703.6%+493.3%
TTM-210.4%5Y-531.2%+320.8%
5Y-531.2%10Y-719.0%+187.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-210.4%-200.1%-10.3%
TTM-210.4%-216.8%+6.4%
YOY-703.6%-288.3%-415.3%
5Y-531.2%-449.1%-82.1%
10Y-719.0%-605.5%-113.5%
1.1.2. Return on Assets

Shows how efficient Harpoon Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • -91.1% Return on Assets means that Harpoon Therapeutics Inc generated $-0.91 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harpoon Therapeutics Inc:

  • The MRQ is -91.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -91.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-91.1%TTM-91.1%0.0%
TTM-91.1%YOY-107.1%+16.0%
TTM-91.1%5Y-56.3%-34.8%
5Y-56.3%10Y-67.2%+10.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-91.1%-13.3%-77.8%
TTM-91.1%-12.8%-78.3%
YOY-107.1%-11.7%-95.4%
5Y-56.3%-13.9%-42.4%
10Y-67.2%-15.7%-51.5%
1.1.3. Return on Equity

Shows how efficient Harpoon Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • -1,243.5% Return on Equity means Harpoon Therapeutics Inc generated $-12.44 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harpoon Therapeutics Inc:

  • The MRQ is -1,243.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1,243.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1,243.5%TTM-1,243.5%0.0%
TTM-1,243.5%YOY-286.6%-956.9%
TTM-1,243.5%5Y-334.3%-909.2%
5Y-334.3%10Y-238.8%-95.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,243.5%-16.9%-1,226.6%
TTM-1,243.5%-16.1%-1,227.4%
YOY-286.6%-15.1%-271.5%
5Y-334.3%-19.3%-315.0%
10Y-238.8%-20.2%-218.6%

1.2. Operating Efficiency of Harpoon Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Harpoon Therapeutics Inc is operating .

  • Measures how much profit Harpoon Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of -214.1% means the company generated $-2.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harpoon Therapeutics Inc:

  • The MRQ is -214.1%. The company is operating very inefficient. -2
  • The TTM is -214.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-214.1%TTM-214.1%0.0%
TTM-214.1%YOY-493.6%+279.5%
TTM-214.1%5Y-519.8%+305.7%
5Y-519.8%10Y-705.1%+185.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-214.1%-296.2%+82.1%
TTM-214.1%-232.5%+18.4%
YOY-493.6%-298.2%-195.4%
5Y-519.8%-492.1%-27.7%
10Y-705.1%-632.4%-72.7%
1.2.2. Operating Ratio

Measures how efficient Harpoon Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.24 means that the operating costs are $3.24 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 3.238. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.238. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.238TTM3.2380.000
TTM3.238YOY3.936-0.698
TTM3.2385Y8.356-5.118
5Y8.35610Y12.195-3.839
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2383.231+0.007
TTM3.2383.310-0.072
YOY3.9363.890+0.046
5Y8.3565.739+2.617
10Y12.1957.876+4.319

1.3. Liquidity of Harpoon Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Harpoon Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.04 means the company has $1.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 1.044. The company is just able to pay all its short-term debts.
  • The TTM is 1.044. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.044TTM1.0440.000
TTM1.044YOY2.328-1.285
TTM1.0445Y4.064-3.021
5Y4.06410Y3.822+0.242
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0443.890-2.846
TTM1.0444.173-3.129
YOY2.3285.344-3.016
5Y4.0646.126-2.062
10Y3.8226.448-2.626
1.3.2. Quick Ratio

Measures if Harpoon Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.04 means the company can pay off $1.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 1.042. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.042. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.042TTM1.0420.000
TTM1.042YOY3.828-2.786
TTM1.0425Y5.441-4.399
5Y5.44110Y4.780+0.661
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0423.514-2.472
TTM1.0423.998-2.956
YOY3.8285.380-1.552
5Y5.4416.105-0.664
10Y4.7806.404-1.624

1.4. Solvency of Harpoon Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Harpoon Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Harpoon Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.93 means that Harpoon Therapeutics Inc assets are financed with 92.7% credit (debt) and the remaining percentage (100% - 92.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 0.927. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.927. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.927TTM0.9270.000
TTM0.927YOY0.626+0.300
TTM0.9275Y0.845+0.081
5Y0.84510Y1.188-0.343
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9270.339+0.588
TTM0.9270.336+0.591
YOY0.6260.271+0.355
5Y0.8450.366+0.479
10Y1.1880.389+0.799
1.4.2. Debt to Equity Ratio

Measures if Harpoon Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 1,265.6% means that company has $12.66 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harpoon Therapeutics Inc:

  • The MRQ is 12.656. The company is unable to pay all its debts with equity. -1
  • The TTM is 12.656. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ12.656TTM12.6560.000
TTM12.656YOY1.677+10.979
TTM12.6565Y3.479+9.177
5Y3.47910Y2.485+0.994
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.6560.388+12.268
TTM12.6560.402+12.254
YOY1.6770.335+1.342
5Y3.4790.426+3.053
10Y2.4850.461+2.024

2. Market Valuation of Harpoon Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Harpoon Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Harpoon Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -0.23 means the investor is paying $-0.23 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harpoon Therapeutics Inc:

  • The EOD is -7.269. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.229. Based on the earnings, the company is expensive. -2
  • The TTM is -0.229. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.269MRQ-0.229-7.040
MRQ-0.229TTM-0.2290.000
TTM-0.229YOY-1.384+1.155
TTM-0.2295Y-2.886+2.657
5Y-2.88610Y-2.061-0.825
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.269-2.264-5.005
MRQ-0.229-2.629+2.400
TTM-0.229-2.680+2.451
YOY-1.384-4.145+2.761
5Y-2.886-6.257+3.371
10Y-2.061-6.254+4.193
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harpoon Therapeutics Inc:

  • The EOD is -5.499. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.174. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.174. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.499MRQ-0.174-5.326
MRQ-0.174TTM-0.1740.000
TTM-0.174YOY-1.321+1.148
TTM-0.1745Y-17.822+17.648
5Y-17.82210Y-12.730-5.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.499-2.973-2.526
MRQ-0.174-3.333+3.159
TTM-0.174-3.553+3.379
YOY-1.321-5.605+4.284
5Y-17.822-8.376-9.446
10Y-12.730-8.865-3.865
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Harpoon Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.88 means the investor is paying $2.88 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Harpoon Therapeutics Inc:

  • The EOD is 91.193. Based on the equity, the company is expensive. -2
  • The MRQ is 2.877. Based on the equity, the company is underpriced. +1
  • The TTM is 2.877. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD91.193MRQ2.877+88.315
MRQ2.877TTM2.8770.000
TTM2.877YOY2.782+0.095
TTM2.8775Y3.124-0.247
5Y3.12410Y2.231+0.893
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD91.1931.896+89.297
MRQ2.8772.115+0.762
TTM2.8772.093+0.784
YOY2.7822.884-0.102
5Y3.1243.542-0.418
10Y2.2313.916-1.685
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Harpoon Therapeutics Inc.

3.1. Institutions holding Harpoon Therapeutics Inc

Institutions are holding 82.854% of the shares of Harpoon Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Cormorant Asset Management, LLC10.97831.077234906022950004245.283
2023-12-31COMMODORE CAPITAL LP7.01031.4902150000015000000
2023-12-31RA Capital Management, LLC7.01030.2664150000015000000
2023-12-31Franklin Resources Inc6.97460.0079149236813600411027.788
2023-12-31Artal Group S A6.09480.4929130412712041271204.127
2023-12-31Vanguard Group Inc4.11280.0002880017766655676.2892
2023-12-31Soleus Capital Management, L.P.3.83531.03538206388206380
2023-12-31Blackstone Inc3.80890.04178150008150000
2023-12-31Ally Bridge Group (NY) LLC2.00212.90244284004284000
2023-12-31MPM Oncology Impact Management LP1.4940.850431967000
2023-12-31Mpm Asset Management, LLC1.46341.74963131363131360
2023-12-31Adage Capital Partners Gp LLC1.40210.00713000003000000
2023-12-31Sio Capital Management, LLC1.39240.771329793612991977.3249
2023-12-31BlackRock Inc1.16760.0001249834212895576.3421
2023-12-31Lion Point Capital, LP1.06981.3022228900146442177.5959
2023-12-31Geode Capital Management, LLC0.69760.0002149262124349499.133
2023-12-31Goldman Sachs Group Inc0.45750.000197896978960
2023-12-31Kennedy Capital Management Inc0.24380.01352160-827-1.5608
2023-09-30Citadel Advisors Llc0.22790487564869276081.25
2023-12-31Citigroup Inc0.18330.000339222392220
Total 61.626812.008313186382+12101585+91.8%

3.2. Funds holding Harpoon Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.29580.000749124100
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.02110.0049218485-210-0.096
2024-01-31Fidelity Extended Market Index0.37210.0057962600
2023-12-31Kennedy Micro Cap0.24370.125152150-837-1.5796
2024-02-29First Trust Merger Arbitrage ETF0.16121.57163449200
2023-12-31BlackRock Extended Equity Market K0.15890.00283400529229611.9975
2024-01-311290 VT GAMCO Mergers & Acquisitions IB0.14960.424132000320000
2024-02-29IQ Merger Arbitrage ETF0.12790.21212737400
2024-02-29abrdn Life Sciences Investors0.12150.13482599100
2024-01-31Fidelity Total Market Index0.11870.00072539100
2024-02-29iShares Core S&P Total US Stock Mkt ETF0.10770.0012304800
2024-01-31Morningstar Alternatives0.10640.217522766227660
2024-02-29Pender Alternative Arbitrage Plus Cl I0.14.29282140000
2024-01-31Fidelity Series Total Market Index0.09390.000720100-3172-13.6301
2024-02-29Accelerate Arbitrage ETF0.08411.55711800000
2024-02-29Pender Alternative Arbitrage Cl FF0.07622.39441630000
2024-01-31Neuberger Berman Abs Ret Multi-Mgr I0.07030.369715046150460
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06070.00251298211421731.6464
2023-12-31Northern Trust Extended Eq Market Idx0.06070.00251298211421731.6464
2024-02-29Schwab Total Stock Market Index0.05330.00121140100
Total 5.583811.32121194780+117664+9.8%

3.3. Insider Transactions

Insiders are holding 0.346% of the shares of Harpoon Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-11Merck & Co., Inc.BUY2139720523

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Harpoon Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.462-2.4620%0.198-1345%0.302-914%0.036-6929%
Book Value Per Share--0.2520.2520%2.714-91%1.477-83%0.806-69%
Current Ratio--1.0441.0440%2.328-55%4.064-74%3.822-73%
Debt To Asset Ratio--0.9270.9270%0.626+48%0.845+10%1.188-22%
Debt To Equity Ratio--12.65612.6560%1.677+655%3.479+264%2.485+409%
Dividend Per Share----0%-0%-0%-0%
Eps---3.165-3.1650%-5.455+72%-2.966-6%-2.307-27%
Free Cash Flow Per Share---4.184-4.1840%-5.714+37%-2.386-43%-1.784-57%
Free Cash Flow To Equity Per Share---3.886-3.8860%-0.502-87%0.253-1636%0.316-1328%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---57.641--------
Intrinsic Value_10Y_min---73.212--------
Intrinsic Value_1Y_max---3.124--------
Intrinsic Value_1Y_min---4.471--------
Intrinsic Value_3Y_max---11.407--------
Intrinsic Value_3Y_min---15.994--------
Intrinsic Value_5Y_max---22.128--------
Intrinsic Value_5Y_min---30.237--------
Market Cap492349572.000+97%15534367.20015534367.2000%161548860.000-90%169791061.440-91%121279329.600-87%
Net Profit Margin---2.104-2.1040%-7.036+234%-5.312+153%-7.190+242%
Operating Margin---2.141-2.1410%-4.936+131%-5.198+143%-7.051+229%
Operating Ratio--3.2383.2380%3.936-18%8.356-61%12.195-73%
Pb Ratio91.193+97%2.8772.8770%2.782+3%3.124-8%2.231+29%
Pe Ratio-7.269-3069%-0.229-0.2290%-1.384+503%-2.886+1158%-2.061+799%
Price Per Share23.010+97%0.7260.7260%7.550-90%7.935-91%5.668-87%
Price To Free Cash Flow Ratio-5.499-3069%-0.174-0.1740%-1.321+662%-17.822+10171%-12.730+7237%
Price To Total Gains Ratio-9.348-3069%-0.295-0.2950%38.182-101%7.807-104%7.807-104%
Quick Ratio--1.0421.0420%3.828-73%5.441-81%4.780-78%
Return On Assets---0.911-0.9110%-1.071+18%-0.563-38%-0.672-26%
Return On Equity---12.435-12.4350%-2.866-77%-3.343-73%-2.388-81%
Total Gains Per Share---2.462-2.4620%0.198-1345%0.302-914%0.036-6929%
Usd Book Value--5399000.0005399000.0000%58070000.000-91%31609800.000-83%17237428.571-69%
Usd Book Value Change Per Share---2.462-2.4620%0.198-1345%0.302-914%0.036-6929%
Usd Book Value Per Share--0.2520.2520%2.714-91%1.477-83%0.806-69%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---3.165-3.1650%-5.455+72%-2.966-6%-2.307-27%
Usd Free Cash Flow---89529000.000-89529000.0000%-122254000.000+37%-51055600.000-43%-38169428.571-57%
Usd Free Cash Flow Per Share---4.184-4.1840%-5.714+37%-2.386-43%-1.784-57%
Usd Free Cash Flow To Equity Per Share---3.886-3.8860%-0.502-87%0.253-1636%0.316-1328%
Usd Market Cap492349572.000+97%15534367.20015534367.2000%161548860.000-90%169791061.440-91%121279329.600-87%
Usd Price Per Share23.010+97%0.7260.7260%7.550-90%7.935-91%5.668-87%
Usd Profit---67137000.000-67137000.0000%-166435000.000+148%-71862200.000+7%-55363857.143-18%
Usd Revenue--31915000.00031915000.0000%23654000.000+35%16708000.000+91%12035428.571+165%
Usd Total Gains Per Share---2.462-2.4620%0.198-1345%0.302-914%0.036-6929%
 EOD+5 -3MRQTTM+0 -0YOY+12 -215Y+7 -2610Y+6 -27

4.2. Fundamental Score

Let's check the fundamental score of Harpoon Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.269
Price to Book Ratio (EOD)Between0-191.193
Net Profit Margin (MRQ)Greater than0-2.104
Operating Margin (MRQ)Greater than0-2.141
Quick Ratio (MRQ)Greater than11.042
Current Ratio (MRQ)Greater than11.044
Debt to Asset Ratio (MRQ)Less than10.927
Debt to Equity Ratio (MRQ)Less than112.656
Return on Equity (MRQ)Greater than0.15-12.435
Return on Assets (MRQ)Greater than0.05-0.911
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Harpoon Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5082.718
Ma 20Greater thanMa 5022.792
Ma 50Greater thanMa 10021.176
Ma 100Greater thanMa 20014.904
OpenGreater thanClose23.010
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets73,729
Total Liabilities68,330
Total Stockholder Equity5,399
 As reported
Total Liabilities 68,330
Total Stockholder Equity+ 5,399
Total Assets = 73,729

Assets

Total Assets73,729
Total Current Assets54,727
Long-term Assets19,002
Total Current Assets
Cash And Cash Equivalents 51,614
Short-term Investments 1,498
Other Current Assets 1,615
Total Current Assets  (as reported)54,727
Total Current Assets  (calculated)54,727
+/-0
Long-term Assets
Property Plant Equipment 18,091
Other Assets 911
Long-term Assets  (as reported)19,002
Long-term Assets  (calculated)19,002
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities52,433
Long-term Liabilities15,897
Total Stockholder Equity5,399
Total Current Liabilities
Short-term Debt 2,423
Accounts payable 4,712
Other Current Liabilities 14,361
Total Current Liabilities  (as reported)52,433
Total Current Liabilities  (calculated)21,496
+/- 30,937
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt13,583
Other Liabilities 2,314
Long-term Liabilities  (as reported)15,897
Long-term Liabilities  (calculated)15,897
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -352,523
Accumulated Other Comprehensive Income -3
Other Stockholders Equity 357,921
Total Stockholder Equity (as reported)5,399
Total Stockholder Equity (calculated)5,399
+/-0
Other
Capital Stock4
Cash and Short Term Investments 53,112
Common Stock Shares Outstanding 3,317
Current Deferred Revenue30,937
Liabilities and Stockholders Equity 73,729
Net Debt -35,608
Net Invested Capital 5,399
Net Tangible Assets 5,399
Net Working Capital 2,294
Property Plant and Equipment Gross 26,634
Short Long Term Debt Total 16,006



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
8,384
31,872
102,580
176,604
171,592
155,452
73,729
73,729155,452171,592176,604102,58031,8728,384
   > Total Current Assets 
8,294
29,647
90,223
150,617
129,754
137,695
54,727
54,727137,695129,754150,61790,22329,6478,294
       Cash And Cash Equivalents 
985
29,423
89,493
155,129
21,170
44,687
51,614
51,61444,68721,170155,12989,49329,423985
       Short-term Investments 
0
0
0
59,337
104,860
90,411
1,498
1,49890,411104,86059,337000
       Net Receivables 
6,750
0
0
0
0
860
0
086000006,750
       Other Current Assets 
559
224
730
2,544
3,724
2,597
1,615
1,6152,5973,7242,544730224559
   > Long-term Assets 
90
2,225
12,357
25,987
41,838
17,757
19,002
19,00217,75741,83825,98712,3572,22590
       Property Plant Equipment 
90
2,087
2,998
18,398
16,771
15,375
18,091
18,09115,37516,77118,3982,9982,08790
       Long Term Investments 
0
0
0
7,056
23,946
1,522
0
01,52223,9467,056000
       Other Assets 
0
138
9,359
533
1,121
860
911
9118601,1215339,3591380
> Total Liabilities 
18,828
58,815
156,059
82,384
117,753
97,382
68,330
68,33097,382117,75382,384156,05958,81518,828
   > Total Current Liabilities 
3,862
6,916
11,948
22,513
47,918
59,139
52,433
52,43359,13947,91822,51311,9486,9163,862
       Short-term Debt 
2,312
0
0
1,217
1,202
1,649
2,423
2,4231,6491,2021,217002,312
       Short Long Term Debt 
2,312
0
0
0
0
0
0
0000002,312
       Accounts payable 
281
1,174
4,357
2,594
1,572
2,666
4,712
4,7122,6661,5722,5944,3571,174281
       Other Current Liabilities 
3,581
1,492
3,341
7,495
13,845
17,362
14,361
14,36117,36213,8457,4953,3411,4923,581
   > Long-term Liabilities 
14,966
51,899
144,111
59,871
69,835
38,243
15,897
15,89738,24369,83559,871144,11151,89914,966
       Capital Lease Obligations 
0
0
0
14,944
13,515
12,187
16,006
16,00612,18713,51514,944000
       Warrants
0
0
129,577
0
0
0
0
0000129,57700
       Other Liabilities 
40
12,058
14,534
46,144
57,522
27,705
2,314
2,31427,70557,52246,14414,53412,05840
       Long-term Liabilities Other 
40
16
6,742
59,871
69,835
0
0
0069,83559,8716,7421640
       Deferred Long Term Liability 
0
0
3,000
0
600
200
0
020060003,00000
> Total Stockholder Equity
-10,444
-26,943
-53,479
94,220
53,839
58,070
5,399
5,39958,07053,83994,220-53,479-26,943-10,444
   Retained Earnings -352,523-284,792-168,071-118,163-62,591-35,225-18,395
   Accumulated Other Comprehensive Income 
-24
-370
-1,014
41
3
-47
-3
-3-47341-1,014-370-24
   Capital Surplus 
7,978
8,309
9,111
212,339
221,904
342,905
0
0342,905221,904212,3399,1118,3097,978
   Treasury Stock0000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue37,341
Cost of Revenue--
Gross Profit-37,341
 
Operating Income (+$)
Gross Profit-
Operating Expense-74,735
Operating Income-37,394-74,735
 
Operating Expense (+$)
Research Development58,631
Selling General Administrative16,104
Selling And Marketing Expenses-
Operating Expense74,73574,735
 
Net Interest Income (+$)
Interest Income1,863
Interest Expense--
Other Finance Cost-3,744
Net Interest Income-1,881
 
Pretax Income (+$)
Operating Income-37,394
Net Interest Income-1,881
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-30,498-46,171
EBIT - interestExpense = 0
-30,498
-30,498
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--30,498
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-30,498
Tax Provision--
Net Income From Continuing Ops-30,498-30,498
Net Income-30,498
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net8,7771,881
 

Technical Analysis of Harpoon Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Harpoon Therapeutics Inc. The general trend of Harpoon Therapeutics Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Harpoon Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Harpoon Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 26.50 < 28.45 < 28.90.

The bearish price targets are: 22.97 > 22.93 > 22.93.

Tweet this
Harpoon Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Harpoon Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Harpoon Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Harpoon Therapeutics Inc. The current macd is 0.54554957.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Harpoon Therapeutics Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Harpoon Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Harpoon Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Harpoon Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartHarpoon Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Harpoon Therapeutics Inc. The current adx is 69.95.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Harpoon Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Harpoon Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Harpoon Therapeutics Inc. The current sar is 22.79.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Harpoon Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Harpoon Therapeutics Inc. The current rsi is 82.72. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
Harpoon Therapeutics Inc Daily Relative Strength Index (RSI) ChartHarpoon Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Harpoon Therapeutics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Harpoon Therapeutics Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Harpoon Therapeutics Inc Daily Stochastic Oscillator ChartHarpoon Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Harpoon Therapeutics Inc. The current cci is 64.27.

Harpoon Therapeutics Inc Daily Commodity Channel Index (CCI) ChartHarpoon Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Harpoon Therapeutics Inc. The current cmo is 69.74.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Harpoon Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartHarpoon Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Harpoon Therapeutics Inc. The current willr is -22.59887006.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Harpoon Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Harpoon Therapeutics Inc Daily Williams %R ChartHarpoon Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Harpoon Therapeutics Inc.

Harpoon Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Harpoon Therapeutics Inc. The current atr is 0.18204122.

Harpoon Therapeutics Inc Daily Average True Range (ATR) ChartHarpoon Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Harpoon Therapeutics Inc. The current obv is 28,534,838.

Harpoon Therapeutics Inc Daily On-Balance Volume (OBV) ChartHarpoon Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Harpoon Therapeutics Inc. The current mfi is 70.71.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Harpoon Therapeutics Inc Daily Money Flow Index (MFI) ChartHarpoon Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Harpoon Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-10-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-10-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-10-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Harpoon Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Harpoon Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5082.718
Ma 20Greater thanMa 5022.792
Ma 50Greater thanMa 10021.176
Ma 100Greater thanMa 20014.904
OpenGreater thanClose23.010
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Harpoon Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Harpoon Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Harpoon Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Harpoon Therapeutics Inc

I send you an email if I find something interesting about Harpoon Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Harpoon Therapeutics Inc.

Receive notifications about Harpoon Therapeutics Inc in your mailbox!